Citigroup
SANA icon

Citigroup’s Sana Biotechnology SANA Stock Holding History

Citigroup’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,700
Closed -$61.2K – 5937
2024
Q3 		$61.2K Sell
14,700
-200
-1% -$1.05K ﹤0.01% 4960
2024
Q2 		$81.4K Buy
+14,900
New +$119K ﹤0.01% 4320

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Citigroup's SANA Position: Q2 2026 in Review

Citigroup increased its Sana Biotechnology (SANA) stake by 351% in Q2 2026, buying an estimated $683K and bringing the position to 272,524 shares worth $951K. The position accounts for ﹤0.01% of the portfolio, ranked #3480.

Citigroup first reported a position in SANA in Q1 2021 and has held it in 22 quarters since. The position peaked at $4.7M in Q1 2024. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Citigroup held 272,524 shares of Sana Biotechnology worth $951K as of Q2 2026.
  • Citigroup bought 212,133 Sana Biotechnology shares in Q2 2026, an estimated $683K.
  • Sana Biotechnology made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3480 holding.
  • Citigroup first reported a position in Sana Biotechnology in Q1 2021 and has held it in 22 quarters since.
  • Citigroup's Sana Biotechnology position peaked at $4.7M in Q1 2024.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.